Aviso Wealth Management Buys 5,540 Shares of CME Group Inc. (NASDAQ:CME)

Aviso Wealth Management increased its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 287.0% in the second quarter, Holdings Channel.com reports. The firm owned 7,470 shares of the financial services provider’s stock after buying an additional 5,540 shares during the quarter. CME Group comprises approximately 0.9% of Aviso Wealth Management’s investment portfolio, making the stock its 27th biggest position. Aviso Wealth Management’s holdings in CME Group were worth $1,469,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Sepio Capital LP increased its holdings in shares of CME Group by 26.3% during the second quarter. Sepio Capital LP now owns 4,387 shares of the financial services provider’s stock worth $862,000 after buying an additional 913 shares in the last quarter. Legal & General Group Plc grew its position in CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the last quarter. MBB Public Markets I LLC bought a new stake in CME Group during the 2nd quarter worth $5,141,000. Dark Forest Capital Management LP acquired a new position in CME Group in the 2nd quarter worth about $601,000. Finally, Ameriprise Financial Inc. raised its position in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Barclays boosted their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $212.54.

View Our Latest Stock Analysis on CME Group

CME Group Trading Down 0.1 %

Shares of CME stock opened at $218.30 on Friday. The company has a market cap of $78.60 billion, a P/E ratio of 24.84, a PEG ratio of 8.74 and a beta of 0.55. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The stock has a 50 day simple moving average of $209.70 and a two-hundred day simple moving average of $207.50. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.30 EPS. Research analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.11%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.